Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Oleic acid induces the novel apolipoprotein O and reduces mitochondrial membrane potential in chicken and human hepatoma cells.

Weijler AM, Schmidinger B, Kapiotis S, Laggner H, Hermann M.

Biochimie. 2018 Apr;147:136-142. doi: 10.1016/j.biochi.2018.02.003. Epub 2018 Feb 10.

PMID:
29432786
2.

The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model: An open-label, controlled, sequential study.

Weisshaar S, Litschauer B, Bucher S, Riesenhuber M, Kapiotis S, Kyrle PA, Wolzt M.

Medicine (Baltimore). 2016 Jul;95(27):e4145. doi: 10.1097/MD.0000000000004145.

3.

The uremic toxin indoxyl sulfate acts as a pro- or antioxidant on LDL oxidation.

Praschberger M, Hermann M, Wanner J, Jirovetz L, Exner M, Kapiotis S, Gmeiner BM, Laggner H.

Free Radic Biol Med. 2014 Oct;75 Suppl 1:S36. doi: 10.1016/j.freeradbiomed.2014.10.778. Epub 2014 Dec 10.

PMID:
26461354
4.

Vitamin D levels and comorbidities in ambulatory and hospitalized patients in Austria.

Muschitz C, Kocijan R, Stütz V, Kaider A, Muschitz GK, Resch H, Kapiotis S.

Wien Klin Wochenschr. 2015 Sep;127(17-18):675-84. doi: 10.1007/s00508-015-0824-5. Epub 2015 Jul 17.

PMID:
26184408
5.

Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.

Weisshaar S, Litschauer B, Gouya G, Mayer P, Smerda L, Kapiotis S, Kyrle PA, Eichinger S, Wolzt M.

J Thromb Haemost. 2014 Nov;12(11):1850-60. doi: 10.1111/jth.12726. Epub 2014 Oct 16.

6.

Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS Study.

Muschitz C, Kocijan R, Fahrleitner-Pammer A, Pavo I, Haschka J, Schima W, Kapiotis S, Resch H.

J Bone Miner Res. 2014 Aug;29(8):1777-85. doi: 10.1002/jbmr.2216.

7.

The uremic toxin indoxyl sulfate acts as a pro- or antioxidant on LDL oxidation.

Praschberger M, Hermann M, Wanner J, Jirovetz L, Exner M, Kapiotis S, Gmeiner BM, Laggner H.

Free Radic Res. 2014 Jun;48(6):641-8. doi: 10.3109/10715762.2014.898294. Epub 2014 Mar 25.

PMID:
24568219
8.

Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.

Kocijan R, Muschitz C, Fahrleitner-Pammer A, Amrein K, Pietschmann P, Haschka J, Dinu S, Kapiotis S, Resch H.

J Clin Endocrinol Metab. 2014 Feb;99(2):E311-9. doi: 10.1210/jc.2013-2244. Epub 2013 Nov 7.

PMID:
24203063
9.

Carbamoylation abrogates the antioxidant potential of hydrogen sulfide.

Praschberger M, Hermann M, Laggner C, Jirovetz L, Exner M, Kapiotis S, Gmeiner BM, Laggner H.

Biochimie. 2013 Nov;95(11):2069-75. doi: 10.1016/j.biochi.2013.07.018. Epub 2013 Jul 26.

PMID:
23896375
10.

Open-label, randomized study of the effect of rivaroxaban with or without acetylsalicylic acid on thrombus formation in a perfusion chamber.

Wolzt M, Gouya G, Kapiotis S, Becka M, Mueck W, Kubitza D.

Thromb Res. 2013 Aug;132(2):240-7. doi: 10.1016/j.thromres.2013.05.019. Epub 2013 Jun 18.

PMID:
23786894
11.

The LPS-induced increase in circulating microparticles is not affected by vitamin C in humans.

Weisshaar S, Gouya G, Nguyen D, Kapiotis S, Wolzt M.

Eur J Clin Invest. 2013 Jul;43(7):708-15. doi: 10.1111/eci.12096. Epub 2013 Apr 18.

PMID:
23594362
12.

Bioactivity of enoxaparin in critically ill patients with normal renal function.

Gouya G, Palkovits S, Kapiotis S, Madl C, Locker G, Stella A, Wolzt M, Heinz G.

Br J Clin Pharmacol. 2012 Nov;74(5):806-14.

13.

Carbamoylated free amino acids in uremia: HOCl generates volatile protein modifying and cytotoxic oxidant species from N-carbamoyl-threonine but not threonine.

Schreier SM, Hollaus M, Hermann M, Jirovetz L, Exner M, Kapiotis S, Gmeiner BM, Laggner H.

Biochimie. 2012 Nov;94(11):2441-7. doi: 10.1016/j.biochi.2012.06.032. Epub 2012 Jul 7.

PMID:
22776434
14.

Human pharmacokinetics of intravenous recombinant human Cu/Zn superoxide dismutase.

Schaller G, Dittrich P, Felizeter M, Gouya G, Leuchten N, Kapiotis S, Vcelar B, Vorauer-Uhl K, Wolzt M.

Int J Clin Pharmacol Ther. 2012 Jun;50(6):413-7. doi: 10.5414/CP201651.

PMID:
22541746
15.

The effect of erythropoietin on platelet and endothelial activation markers: a prospective trial in healthy volunteers.

Heinisch BB, Vcelar B, Kapiotis S, Blann A, Wolzt M, Siller-Matula JM, Jilma B.

Platelets. 2012;23(5):352-8. doi: 10.3109/09537104.2011.631621. Epub 2011 Nov 18.

PMID:
22098110
16.

Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists.

Wolzt M, Eriksson UG, Gouya G, Leuchten N, Kapiotis S, Elg M, Schützer KM, Zetterstrand S, Holmberg M, Wåhlander K.

Thromb Res. 2012 Apr;129(4):e83-91. doi: 10.1016/j.thromres.2011.08.018. Epub 2011 Sep 16.

PMID:
21925716
17.

Does endovenous laser ablation induce endothelial damage at the saphenofemoral junction?

Heere-Ress E, Veensalu M, Wacheck V, Tzaneva S, Kittler H, Kapiotis S, Wolzt M, Böhler K.

Dermatol Surg. 2011 Oct;37(10):1456-63. doi: 10.1111/j.1524-4725.2011.02106.x. Epub 2011 Jul 26.

PMID:
21790851
18.

Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux.

Wolzt M, Samama MM, Kapiotis S, Ogata K, Mendell J, Kunitada S.

Thromb Haemost. 2011 Jun;105(6):1080-90. doi: 10.1160/TH10-11-0705. Epub 2011 May 5.

PMID:
21544313
19.

S-carbamoylation impairs the oxidant scavenging activity of cysteine: its possible impact on increased LDL modification in uraemia.

Schreier SM, Steinkellner H, Jirovetz L, Hermann M, Exner M, Gmeiner BM, Kapiotis S, Laggner H.

Biochimie. 2011 Apr;93(4):772-7. doi: 10.1016/j.biochi.2011.01.007. Epub 2011 Jan 26.

PMID:
21277933
20.

Vitamin C inhibits NO-induced stabilization of HIF-1alpha in HUVECs.

Muellner MK, Schreier SM, Schmidbauer B, Moser M, Quehenberger P, Kapiotis S, Goldenberg H, Laggner H.

Free Radic Res. 2010 Jul;44(7):783-91. doi: 10.3109/10715761003786172.

PMID:
20380593
21.

Effects of endothelin-1 and phenylephrine on plasma levels of von Willebrand factor and protein S.

Leitner GC, Schmetterer L, Kapiotis S, Jilma B.

Thromb Res. 2010 Jan;125(1):e5-8. doi: 10.1016/j.thromres.2009.08.004. Epub 2009 Sep 3.

PMID:
19729191
22.

Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE.

Schreier SM, Muellner MK, Steinkellner H, Hermann M, Esterbauer H, Exner M, Gmeiner BM, Kapiotis S, Laggner H.

Neurotox Res. 2010 Apr;17(3):249-56. doi: 10.1007/s12640-009-9099-9. Epub 2009 Aug 13.

PMID:
19680736
23.

Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL.

Muellner MK, Schreier SM, Laggner H, Hermann M, Esterbauer H, Exner M, Gmeiner BM, Kapiotis S.

Biochem J. 2009 May 13;420(2):277-81. doi: 10.1042/BJ20082421.

PMID:
19265508
24.

Angiotensin inhibition stimulates PPARgamma and the release of visfatin.

Storka A, Vojtassakova E, Mueller M, Kapiotis S, Haider DG, Jungbauer A, Wolzt M.

Eur J Clin Invest. 2008 Nov;38(11):820-6. doi: 10.1111/j.1365-2362.2008.02025.x.

PMID:
19021699
25.

Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humans.

Schaller G, Kolodjaschna J, Pleiner J, Mittermayer F, Kapiotis S, Schmetterer L, Wolzt M.

Horm Metab Res. 2008 Aug;40(8):549-55. doi: 10.1055/s-2008-1076698. Epub 2008 May 21.

PMID:
18500678
26.

Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.

Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.

Clin Sci (Lond). 2008 Oct;115(7):225-32. doi: 10.1042/CS20070382.

PMID:
18307413
27.

The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells.

Laggner H, Hermann M, Esterbauer H, Muellner MK, Exner M, Gmeiner BM, Kapiotis S.

J Hypertens. 2007 Oct;25(10):2100-4.

PMID:
17885553
28.

Treating hypertriglyceridemia.

Röggla G, Fasan M, Kapiotis S.

CMAJ. 2007 Sep 11;177(6):603; author reply 604-5. No abstract available.

29.

Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion.

Pleiner J, Schaller G, Mittermayer F, Marsik C, MacAllister RJ, Kapiotis S, Ziegler S, Ferlitsch A, Wolzt M.

Atherosclerosis. 2008 Mar;197(1):383-91. Epub 2007 Jul 23.

PMID:
17645881
30.

Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl.

Laggner H, Muellner MK, Schreier S, Sturm B, Hermann M, Exner M, Gmeiner BM, Kapiotis S.

Free Radic Res. 2007 Jul;41(7):741-7.

PMID:
17577734
31.

Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans.

Schaller G, Pleiner J, Mittermayer F, Posch M, Kapiotis S, Wolzt M.

Crit Care Med. 2007 Aug;35(8):1869-75.

PMID:
17568325
32.

Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction.

Mittermayer F, Schaller G, Pleiner J, Krzyzanowska K, Kapiotis S, Roden M, Wolzt M.

J Clin Endocrinol Metab. 2007 Jul;92(7):2574-80. Epub 2007 May 1.

PMID:
17473072
33.

The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?

Laggner H, Schreier S, Hermann M, Exner M, Mühl A, Gmeiner BM, Kapiotis S.

Free Radic Res. 2007 Feb;41(2):234-41.

PMID:
17364950
34.

Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.

Krzyzanowska K, Mittermayer F, Shnawa N, Hofer M, Schnabler J, Etmüller Y, Kapiotis S, Wolzt M, Schernthaner G.

Diabet Med. 2007 Jan;24(1):81-6.

PMID:
17227328
35.

C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.

Haider DG, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L, Kapiotis S, Wolzt M.

Clin Exp Immunol. 2006 Dec;146(3):533-9.

36.

The adipokine visfatin is markedly elevated in obese children.

Haider DG, Holzer G, Schaller G, Weghuber D, Widhalm K, Wagner O, Kapiotis S, Wolzt M.

J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):548-9.

PMID:
17033537
37.

The dietary soy flavonoid genistein abrogates tissue factor induction in endothelial cells induced by the atherogenic oxidized phospholipid oxPAPC.

Holzer G, Esterbauer H, Kronke G, Exner M, Kopp CW, Leitinger N, Wagner O, Gmeiner BM, Kapiotis S.

Thromb Res. 2007;120(1):71-9. Epub 2006 Oct 2.

PMID:
17014893
38.

Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.

Novacek G, Miehsler W, Palkovits J, Reinisch W, Waldhör T, Kapiotis S, Gangl A, Vogelsang H.

World J Gastroenterol. 2006 Oct 7;12(37):6026-31.

39.

A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes.

Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D, Jilma B, Röggla G, Wolzt M, Widhalm K, Wagner OF.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2541-6. Epub 2006 Sep 14.

PMID:
16973973
40.

Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma.

Li S, Beheshti M, Peck-Radosavljevic M, Oezer S, Grumbeck E, Schmid M, Hamilton G, Kapiotis S, Dudczak R, Kletter K.

Liver Int. 2006 Oct;26(8):920-7.

PMID:
16953831
41.

Cu2+ and Cu+ bathocuproine disulfonate complexes promote the oxidation of the ROS-detecting compound dichlorofluorescin (DCFH).

Laggner H, Hermann M, Gmeiner BM, Kapiotis S.

Anal Bioanal Chem. 2006 Jul;385(5):959-61. Epub 2006 May 20.

PMID:
16791578
42.

The release of the adipocytokine visfatin is regulated by glucose and insulin.

Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M.

Diabetologia. 2006 Aug;49(8):1909-14. Epub 2006 May 31.

PMID:
16736128
43.

Anti-inflammatory mechanisms of the Tibetan herbal preparation Padma 28 in the vessel wall.

Exner M, Raith M, Holzer G, Gmeiner B, Wagner O, Kapiotis S.

Forsch Komplementmed. 2006 Feb;13 Suppl 1:13-7. Epub 2006 Feb 17.

PMID:
16582558
44.

Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification.

Kapiotis S, Jirovetz L, Hermann M, Laggner H, Exner M, Esterbauer H, Gmeiner BM.

Biochimie. 2006 Jul;88(7):785-91. Epub 2006 Feb 2.

PMID:
16488068
45.

Aluminum ions stimulate the oxidizability of low density lipoprotein by Fe2+: implication in hemodialysis mediated atherogenic LDL modification.

Kapiotis S, Hermann M, Exner M, Sturm BN, Scheiber-Mojdehkar B, Goldenberg H, Kopp S, Chiba P, Gmeiner BM.

Free Radic Res. 2005 Nov;39(11):1225-31.

PMID:
16298749
46.

Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals.

Kapiotis S, Hermann M, Exner M, Laggner H, Gmeiner BM.

Free Radic Res. 2005 Nov;39(11):1193-202.

PMID:
16298745
47.

Sulfite facilitates LDL lipid oxidation by transition metal ions: a pro-oxidant in wine?

Laggner H, Hermann M, Sturm B, Gmeiner BM, Kapiotis S.

FEBS Lett. 2005 Nov 21;579(28):6486-92. Epub 2005 Nov 2.

48.

Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction.

Mittermayer F, Pleiner J, Schaller G, Zorn S, Namiranian K, Kapiotis S, Bartel G, Wolfrum M, Brügel M, Thiery J, Macallister RJ, Wolzt M.

Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1752-7. Epub 2005 Jun 17.

49.

Simvastatin prevents vascular hyporeactivity during inflammation.

Pleiner J, Schaller G, Mittermayer F, Zorn S, Marsik C, Polterauer S, Kapiotis S, Wolzt M.

Circulation. 2004 Nov 23;110(21):3349-54. Epub 2004 Nov 1.

PMID:
15520323
50.

Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.

Exner M, Hermann M, Hofbauer R, Hartmann B, Kapiotis S, Gmeiner B.

Free Radic Biol Med. 2004 Jul 15;37(2):146-55.

PMID:
15203186

Supplemental Content

Loading ...
Support Center